(Q42990184)

English

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

scientific article published on 15 March 2013

Statements

Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial (English)
Eric Lawitz
Israel Crespo
Tarek Hassanein
Michael DeMicco
David E Bernstein
John M Vierling
Stuart C Gordon
Jane K Anderson
Robert H Hyland
Robert G Hindes
Efsevia Albanis
William T Symonds
M Michelle Berrey
David R Nelson
Ira M Jacobson
15 March 2013
9883
2100-2107

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit